SynthesisObesity surgery2026
Effect of Calcium Citrate Versus Calcium Carbonate on Parathyroid Hormone Levels in Patients Undergoing Bariatric Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Synthesis in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parathyroid hormone (PTH) is important in bariatric patients for understandingcalcium homeostasis and bone health. The effects of calcium carbonate and calcium citrate onPTH levels need further investigation in this population. This systematic review and meta-analysis of randomized clinical trials investigated the effect of calcium citrate versus calciumcarbonate on PTH levels in patients undergoing bariatric surgery, using the PRISMA guidelines. Atotal of 227 participants from four studies were included in the meta-analysis. Pooled analysisshowed no significant differences between the effect of calcium citrate versus calcium carbonateon serum calcium levels (WMD: 0.03 mg/dl, 95% CI: -0.04,0.11;I=35.7%) and PTH levels(WMD: 0 pg/ml, 95%CI: -2.81,2.82;I=73.5). Subgroup analysis showed that a single dose of calcium citrate significantly reduced PTH levels better than calcium carbonate (WMD: -1.17, 95%CI: -2.04,-0.29; I2=0%), but no significant difference was observed in chronic interventions (WMD: 2.05, 95% CI: -3.68, 7.78; I =81.4%). Furthermore, single dose of calcium citrate increased serum levels of calcium AUC (WMD: 1.28, 95% CI: 0.58, 1.99; I =0%) and calcium Cmax (WMD: 0.28, 95% CI: 0.19, 0.37; I =0%), and decreased PTH AUC (WMD: -30.65, 95% CI:-45.49, -15.81; I =0%), more than calcium carbonate. In conclusion, a single dose of calcium citrate is superior to calcium carbonate in reducing PTH levels in patients undergoing bariatric surgery, but no difference was observed over time between the formulations.
Indexed as
Identifiers
41806228What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.